Kaposi sarcoma associated with rituximab-based cytotoxic therapy-Reference-Cited by-同舟云学术

Kaposi sarcoma associated with rituximab-based cytotoxic therapy

Published:2019-03-09 Issue:1 Volume:26 Page:220-223
ISSN:1078-1552
Container-title:Journal of Oncology Pharmacy Practice
language:en
Short-container-title:J Oncol Pharm Pract

Author:

Alkan Ali¹^ORCID,Yaşar Arzu²^ORCID,Toprak Serhat³

Affiliation:

1. Department of Internal Medicine, Medical Oncology Unit, Muğla S|tk| Koçman University School of Medicine, Muğla, Turkey

2. Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey

3. Department of Pathology, İnönü University School of Medicine, Turgut Özal Medical Center, Malatya, Turkey

Abstract

Kaposi sarcoma (KS) is a low-grade mesenchymal angioproliferative disease, mostly observed in immune compromised patients. KS is mostly encountered in HIV-positive or organ transplant patients. The drugs causing immunosuppression have also been associated with KS. Here, we present a KS experience associated with rituximab-based therapy.

Publisher

SAGE Publications

Subject

Pharmacology (medical),Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1078155219835592

Reference15 articles.

1. Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma

2. A method for estimating the probability of adverse drug reactions

3. Letter to the editor

4. Disseminated cutaneous and visceral Kaposi sarcoma in a woman with rheumatoid arthritis receiving leflunomide

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab-Induced Kaposi Sarcoma in HIV-Negative Patients: A Narrative Review;Cureus;2023-09-16

2. Bullous kaposi sarcoma induced by rituximab for leukemia. case report;Journal of Dermatology & Cosmetology;2022-09-07

3. Iatrogenic Kaposi’s sarcoma induced by rituximab and corticosteroid treatment for pemphigus vegetans in an HIV-negative patient;Indian Journal of Dermatology, Venereology and Leprology;2022-02-01

4. Kaposi's sarcoma, biologics and small molecules: Navigating the complex interplay between host immunity and viral biology. A case series with focused review of the literature;Dermatologic Therapy;2021-12-27

5. Antineoplastics/immunosuppressant;Reactions Weekly;2020-01